Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Obalon Therapeutics Inc    OBLN

OBALON THERAPEUTICS INC (OBLN)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/16/2018 04/17/2018 04/18/2018 04/19/2018 04/20/2018 Date
3.27(c) 3.37(c) 3.45(c) 3.51(c) 3.39(c) Last
42 912 23 825 43 032 15 081 26 205 Volume
-4.66% +3.06% +2.37% +1.74% -3.42% Change
More quotes
Financials (USD)
Sales 2018 16,7 M
EBIT 2018 -34,7 M
Net income 2018 -36,4 M
Debt 2018 -
Yield 2018 -
Sales 2019 30,4 M
EBIT 2019 -31,1 M
Net income 2019 -30,0 M
Debt 2019 -
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales2018 3,57x
Capi. / Sales2019 1,96x
Capitalization 59,7 M
More Financials
Company
Obalon Therapeutics, Inc. focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss.Its product includes medical balloon technology for weight loss therapy which consists of a capsule containing a balloon that is swallowed and then... 
More about the company
Surperformance© ratings of Obalon Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on OBALON THERAPEUTICS INC
04/16OBALON THERAPEUTICS INC : DEADLINE TODAY: The Schall Law Firm Announces the Fili..
AC
04/13OBALON THERAPEUTICS INC : DEADLINE MONDAY: The Schall Law Firm Announces the Fil..
AC
04/13APRIL 16TH DEADLINE ALERT : The Law Offices of Howard G. Smith Reminds Investors..
BU
04/12OBALON THERAPEUTICS INC : 4-Day Deadline Alert: The Schall Law Firm Announces th..
AC
04/12OBALON THERAPEUTICS : Scott+Scott, Attorneys at Law, LLP Reminds Investors of Se..
PR
04/12OBLN Law Offices of Howard G. Smith Announces the Filing of a Securities Clas..
BU
04/11OBALON THERAPEUTICS INC : APRIL 16 DEADLINE: The Schall Law Firm Announces the F..
AC
04/11OBALON THERAPEUTICS INC : April 16 DEADLINE: The Schall Law Firm Announces the F..
AC
04/11GLANCY PRONGAY & MURRAY LLP : Reminds Investors of the April 16, 2018 Deadline i..
BU
04/10OBALON THERAPEUTICS INC : 6-Day Deadline Alert: The Schall Law Firm Announces th..
AC
More news
Sector news : Medical Devices & Implants
04/19China May Request Minor Restrictions for Essilor Merger, Says Luxottica Chair..
DJ
04/19LUXOTTICA : chairman says China may seek 'minor restrictions' to clear Essilor d..
RE
04/04Smith & Nephew picks new CEO who sold his last company
RE
03/12Sensirion, Medartis to raise cash in Swiss IPO boom
RE
03/12STRAUMANN : Medartis to use IPO proceeds to expand amid rising implant demand
RE
More sector news : Medical Devices & Implants
Latest Tweets
04/20Want the latest analyst ratings on $OR $QES $OBLN $COUP $WAAS? Get Them Deliv.. 
04/20Obalon Therapeutics upgraded by Zacks Investment Research to hold.  
04/17Obalon Therapeutics $OBLN vs. AtriCure $ATRC Head to Head Comparison  
04/16Obalon Therapeutics Inc : DEADLINE TODAY: The Schall Law Firm Announces the F.. 
04/13Scott+Scott, Attorneys at Law, LLP Reminds Investors of Securities Class Acti..
1
More tweets
Qtime:57
News from SeekingAlpha
03/06Obalon Therapeutics' (OBLN) CEO Andy Rasdal on Q4 2017 Audited Results - Earn.. 
03/05Obalon Therapeutics misses by $0.14, misses on revenue 
02/21YOUR DAILY PHARMA SCOOP : Portola Update, Wave Life Sciences To Collaborate With.. 
02/20Obalon "all clear" after completing inquiry into possible improper FQ4 revenu.. 
01/25YOUR DAILY PHARMA SCOOP : Portola Still Attractive, Johnson & Johnson Reports Q4.. 
Chart OBALON THERAPEUTICS INC
Duration : Period :
Obalon Therapeutics Inc Technical Analysis Chart | OBLN | US67424L1008 | 4-Traders
Technical analysis trends OBALON THERAPEUTICS INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Average target price 6,75 $
Spread / Average Target 99%
EPS Revisions
Managers
NameTitle
Andrew P. Rasdal President, Chief Executive Officer & Director
Kim P. Kamdar Chairman
Kelly Huang Chief Operating Officer
William John Plovanic Chief Financial Officer & Secretary
Mark Brister Chief Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
OBALON THERAPEUTICS INC-48.71%60
STRYKER CORPORATION5.63%61 284
SMITH & NEPHEW4.97%16 563
JAPAN LIFELINE CO., LTD.34.46%2 671
WRIGHT MEDICAL GROUP NV-11.67%2 043
GLAUKOS CORP15.98%1 034